Anti-influenza activity of marchantins, macrocyclic bisbibenzyls contained in liverworts

PLoS ONE

Volumn 6, Issue 5, 2011, Pages

  Iwai, Yuma ^a   Murakami, Kouki ^b   Gomi, Yasuyuki ^b   Hashimoto, Toshihiro ^a   Asakawa, Yoshinori ^a   Okuno, Yoshinobu ^b   Ishikawa, Toyokazu ^b   Hatakeyama, Dai ^a   Echigo, Noriko ^a   Kuzuhara, Takashi ^a  

^a TOKUSHIMA BUNRI UNIVERSITY   (Japan)

^b Osaka University   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIVIRUS AGENT; ENDONUCLEASE; EPIGALLOCATECHIN GALLATE; MARCHANTIN A; MARCHANTIN B; MARCHANTIN DERIVATIVE; MARCHANTIN E; PERROTTETIN F; PLAGIOCHIN A; PLANT MEDICINAL PRODUCT; UNCLASSIFIED DRUG; MACROCYCLIC COMPOUND;

ANTIVIRAL ACTIVITY; ARTICLE; CONTROLLED STUDY; DRUG SCREENING; DRUG STRUCTURE; GROWTH INHIBITION; IN VITRO STUDY; INFLUENZA VIRUS A; INFLUENZA VIRUS A H1N1; INFLUENZA VIRUS A H3N2; INFLUENZA VIRUS B; MARCHANTIA; MOLECULAR DOCKING; NONHUMAN; STRUCTURE ACTIVITY RELATION; VIRUS INFECTIVITY; VIRUS INHIBITION; ANIMAL; CELL CULTURE; CHEMISTRY; COMPUTER SIMULATION; CYTOLOGY; DOG; DRUG EFFECT; KIDNEY; LIVERWORT; METABOLISM; ORTHOMYXOVIRUS INFECTION; PHYTOTHERAPY; VIROLOGY;

AVIAN INFLUENZA VIRUS; INFLUENZA A VIRUS; MARCHANTIOPHYTA; SUIDAE;

ANIMALS; ANTIVIRAL AGENTS; CELLS, CULTURED; COMPUTER SIMULATION; DOGS; ENDONUCLEASES; HEPATOPHYTA; INFLUENZA A VIRUS, H1N1 SUBTYPE; INFLUENZA A VIRUS, H3N2 SUBTYPE; KIDNEY; MACROCYCLIC COMPOUNDS; ORTHOMYXOVIRIDAE INFECTIONS; PHYTOTHERAPY;

EID: 79956311497     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0019825     Document Type: Article

References (48)

1. Taubenberger JK, Reid AH, Lourens RM, Wang R, Jin G, et al. (2005) Characterization of the 1918 influenza virus polymerase genes. Nature 437: 889-893.
2. Morse SS, (2007) The US pandemic influenza implementation plan at six months. Nat Med 13: 681-684.
3. Horimoto T, Kawaoka Y, (2005) Influenza: lessons from past pandemics, warnings from current incidents. Nat Rev Microbiol 3: 591-600.
4. Hatta M, Gao P, Halfmann P, Kawaoka Y, (2001) Molecular basis for high virulence of Hong Kong H5N1 influenza A viruses. Science 293: 1840-1842.
5. Itoh Y, Shinya K, Kiso M, Watanabe T, Sakoda Y, et al. (2009) In vitro and in vivo characterization of new swine-origin H1N1 influenza viruses. Nature 460: 1021-1025.
6. Neumann G, Noda T, Kawaoka Y, (2009) Emergence and pandemic potential of swine-origin H1N1 influenza virus. Nature 459: 931-939.
7. De Clercq E, (2006) Antiviral agents active against influenza A viruses. Nat Rev Drug Discov 5: 1015-1025.
8. Hayden FG, Atmar RL, Schilling M, Johnson C, Poretz D, et al. (1999) Use of the selective oral neuraminidase inhibitor oseltamivir to prevent influenza. N Engl J Med 341: 1336-1343.
9. Reece PA, (2007) Neuraminidase inhibitor resistance in influenza viruses. J Med Virol 79: 1577-1586.
10. Collins PJ, Haire LF, Lin YP, Liu J, Russell RJ, et al. (2008) Crystal structures of oseltamivir-resistant influenza virus neuraminidase mutants. Nature 453: 1258-1261.
11. Izumi Y, Tokuda K, O'dell KA, Zorumski CF, Narahashi T, (2007) Neuroexcitatory actions of Tamiflu and its carboxylate metabolite. Neurosci Lett 426: 54-58.
12. Honda A, Ishihama A, (1997) The molecular anatomy of influenza virus RNA polymerase. Biol Chem 378: 483-488.
13. Honda A, Mizumoto K, Ishihama A, (2002) Minimum molecular architectures for transcription and replication of the influenza virus. Proc Natl Acad Sci U S A 99: 13166-13171.
14. Kuzuhara T, Kise D, Yoshida H, Horita T, Murazaki Y, et al. (2009) Structural basis of the influenza A virus RNA polymerase PB2 RNA-binding domain containing the pathogenicity-determinant lysine 627 residue. J Biol Chem 284: 6855-6860.
15. Yuan P, Bartlam M, Lou Z, Chen S, Zhou J, et al. (2009) Crystal structure of an avian influenza polymerase PA(N) reveals an endonuclease active site. Nature 458: 909-913.
16. Dias A, Bouvier D, Crépin T, McCarthy AA, Hart DJ, et al. (2009) The cap-snatching endonuclease of influenza virus polymerase resides in the PA subunit. Nature 458: 914-918.
17. Kuzuhara T, Iwai Y, Takahashi H, Hatakeyama D, Echigo N, (2009) Green tea catechins inhibit the endonuclease activity of influenza A virus RNA polymerase. PLoS Curr Oct 13: RRN1052.
18. Asakawa Y, (1982) Progress in the Chemistry of Organic Natural Products. Vol 42, In: Herz W, Grisebach H, Kirby GW, editors. Vienna Springer pp. 1-285.
19. Asakawa Y, (1995) Progress in the Chemistry of Organic Natural Products. Vol 65, In: Herz W, Kirby GW, Moore RE, Steglich W, Tamm Ch, editors. Vienna Springer pp. 1-618.
20. Asakawa Y, (2004) Phytochemistry 65, pp. 623-669.
21. Asakawa Y, (2008) Curr Pharm Design 14, pp. 3067-3088.
22. Asakawa Y, (1999) Phytochemicals in Human Health Protection, Nutrition, and Plant Defense. In: Romeo J, editors. New York Kluwer Academic/Prenum Publishers pp. 319-342.
23. Asakawa Y, (1990) Bryophytes Their Chemistry and Chemotaxonomy of Bryophytes. In: Zinsmeister DH, Mues R, editors. Oxford Clarendon Press pp. 369-410.
24. Asakawa Y, Agnieszka L, Nagashima F, Toyota M, Hashimoto T, et al. (2009) Bryophytes: bio- and chemical diversity, bioactivity and chemosystematics. Heterocycles 77: 99-150.
25. Suzuki T, Tamehiro N, Sato Y, Kobayashi T, Ishii-Watabe A, et al. (2008) The Novel Compounds that Activate Farnesoid X Receptor: the Diversity of Their Effects on Gene Expression. J P0harmacol Sci 107: 285-294.
26. Morita H, Tomizawa Y, Tsuchiya T, Hirasawa Y, Hashimoto T, et al. (2009) Antimitotic Activity of Two Macrocyclic Bis(bibenzyls), Isoplagiochins A and B from the Liverwort Plagiochila fruticosa. Bioorg Med Chem Lett, 19: 493-496.
27. Taira Z, Takei M, Endo K, Hashimoto T, Sakiya Y, et al. (1994) Marchantin A trimethyl ether: its molecular structure and tubocurarine-like skeletal muscle relaxation activity. Chem Pharm Bull 42: 52-56.
28. Harinantenaina L, Quang DN, Takeshi N, Hashimoto T, Kohchi C, et al. (2005) Bis(bibenzyls) from liverworts inhibit lipopolysaccharide-induced inducible NOS in RAW 264.7 cells: a study of structure-activity relationships and molecular mechanism. J Nat Prod 68: 1779-1781.
29. Iwai Y, Takahashi H, Hatakeyama D, Motoshima K, Ishikawa M, et al. (2010) Anti-influenza activity of phenethylphenylphthalimide analogs derived from thalidomide. Bioorg Med Chem 18: 5379-5390.
30. Zhao C, Lou Z, Guo Y, Ma M, Chen Y, et al. (2009) Nucleoside monophosphate complex structures of the endonuclease domain from the influenza virus polymerase PA subunit reveal the substrate binding site inside the catalytic center. J Virol 83: 9024-9030.
31. Morris GM, Goodsell DS, Halliday RS, Huey, R, Hart WE, et al. (1998) Automated docking using Lamarckian genetic algorithm and an empirical binding free energy function. J Comp Chem 19: 1639-1662.
32. Chemical Computing Group C.Molecular Operative Environment (MOE) (2004) 0707.
33. Goto J, Kataoka R, (2008) ASEDock-Docking Based on Alpha Spheres and Excluded Volumes. J Chem Inf Model 48: 583-590.
34. Taub M, Saier MH Jr, (1979) An established but differentiated kidney epithelial cell line (MDCK). Methods Enzymol 58: 552-560.
35. Mahy BWJ, Kangro HO, eds. Virology Methods Manual. Academic Press Limited pp. 35-37.
36. Okuno Y, Tanaka K, Baba K, Maeda A, Kunita N, et al. (1990) Rapid focus reduction neutralization test of influenza A and B viruses in microtiter system. J Clin Microbiol 28: 1308-1313.
37. Thompson JD, Gibson TJ, Plewniak F, Jeanmougin F, Higgins DG, (1997) The ClustalX windows interface: flexible strategies for multiple sequence alignment aided by quality analysis tools. Nucleic Acids Research 24: 4876-4882.
38. Yang CS, Wang X, Lu G, Picinich SC, (2009) Cancer prevention by tea: animal studies, molecular mechanisms and human relevance. Nat Rev Cancer 9: 429-439.
39. Song JM, Lee KH, Seong BL, (2005) Antiviral effect of catechins in green tea on influenza virus. Antiviral Res 68: 66-74.
40. Hashimoto T, Tahara S, Takaoka S, Tori M, Asakawa Y, (1994) Structures of daldinins A-C, three novel azaphylone derivatives from the fungus Daldinia concentrica. Chem Pharm Bull 42: 2397-2399.
41. Hashimoto T, Tahara S, Takaoka S, Tori M, Asakawa Y, (1994) Structures of a novel binaphthyl and three novel benzophenone derivatives with plant-growth inhibitory activity from the fungus Daldinia concentric. Chem Pharm Bull 42: 1376-1378.
42. Hashimoto T, Asakawa Y, Fujiki H, Suganuma M, Yamada S, et al. (2003) Isolation and synthesis of TNF-α release inhibitors from Fijian Kawa (Piper methysticum). Phytomedicine 10: 309-317.
43. Buchanan MS, Hashimoto, T, Takaoka S, Asakawa Y, (1995) (+)-Osmun dalactone, γ-lactones and spiromentins spiromentins from the fungus Paxillus atromentosus, Phytochemistry 40: 1251-1257.
44. Hashimoto T, Yasuda A, Akazawa K, Takaoka S, Tori M, et al. (1994) Three novel dimetyl pyrrole-dicarboxylate, lycogarubins A-C, from the Myxomycetes Lycogala epidendrum. Tetrahedron Letters 35: 2559-2560.
45. Nakamura Y, Oda K, Nakada S, (1991) Growth complementation of influenza virus temperature-sensitive mutants in mouse cells which express the RNA polymerase and nucleoprotein genes. J Biochem 110: 395-401.
46. Mullis KB, Faloona FA, (1987) Specific synthesis of DNA in vitro via a polymerase-catalyzed chain reaction. Methods Enzymol 155: 335-350.
47. Studier FW, Moffatt BA, (1986) Use of bacteriophage T7 RNA polymerase to direct selective high-level expression of cloned genes. J Mol Biol 189: 113-130.
48. Janknecht R, de Martynoff G, Lou J, Hipskind RA, Nordheim A, et al. (1991) Rapid and efficient purification of native histidine-tagged protein expressed by recombinant vaccinia virus. Proc Natl Acad Sci USA 88: 8972-8976.